Mantis Biotech has developed a platform that creates digital twins of humans to address data availability challenges in medicine. This innovation could revolutionize how medical procedures are studied and simulated.
Listen to the article
Hear the article with natural AI narration.
AI explained
How does Mantis Biotech use digital twins in medicine?
Mantis Biotech creates digital twins of humans by integrating diverse data sources into physics-based models. These models simulate anatomy, physiology, and behavior to support medical research and procedure testing.
- Summary: The platform collects data from textbooks, sensors, imaging, and more, then uses an LLM and physics engine to build detailed human digital twins.
- Why it matters: Digital twins help study medical procedures, train surgical robots, and predict health issues where real data is limited.
- Key point: Mantis Biotech’s technology is applied in professional sports and aims to assist pharmaceutical labs and medical researchers.
Mantis Biotech Creates Digital Twins for Medical Research
New York–based Mantis Biotech is working to bridge the data availability gap by integrating various data sources to generate synthetic datasets. These datasets are used to build digital twins of the human body—physics-based, predictive models of anatomy, physiology, and behavior. The platform collects data from sources such as textbooks, motion capture cameras, biometric sensors, workout logs, and medical imaging. It then uses an LLM-based system to validate and synthesize the data, running the information through a physics engine to create high-resolution models.
Digital twins can be used to study and test new medical procedures, train surgical robots, and predict medical issues. For example, a sports organization can predict the likelihood of a player developing an Achilles injury based on performance, training load, and diet. Mantis has already found success in professional sports, with an NBA client using the technology to model high-performance athletes. The company recently raised $7.4 million in seed funding to support further development and marketing of the platform, which will also target pharmaceutical labs and researchers.
Implications for the U.S. Medical and Research Communities
Mantis Biotech’s technology offers promising opportunities for U.S. developers and medical researchers to create more accurate models for medical studies. Given the frequent limitations on data access in healthcare, digital twins can enhance treatment methods and optimize patient care across American hospitals and research institutions.
Source: TechCrunch
Read the full story in Norwegian
Les på norskRead also: Modular Data Centers from Duos and LG for AI Solutions
